RGLS
Regulus Therapeutics Inc
Price:  
8.16 
USD
Volume:  
9,275,199.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGLS Stock Forecast & Price Target

RGLS Stock Price Forecast

The average stock forecast for Regulus Therapeutics Inc (RGLS) in the next 12 months is 8.67 USD. This price target corresponds to an upside of 6.25%. The range of stock forecasts for RGLS is 7.07 - 11.55 USD. Based on the ratings of 12 analysts, the consensus recommendation for RGLS is HOLD.
Target Low Average Median High
Price (USD) 7.07 8.67 8.16 11.55
Upside -13.36% 6.25% -% 41.54%

Recommendation Trends

The latest consensus rating for RGLS is "HOLD". This is the average recommendation of 12 analysts: 0 strong sell, 0 sell, 6 hold, 4 buy, 2 strong buy. In the previous period, 12 analysts also majorly recommmended "HOLD" for RGLS.

RGLS Financial Stock Forecast

Revenue This Year
-M
from -M
Revenue Next Year
-M
from -M
EPS This Year
-0.92
37.09%
from -0.67
EPS Next Year
-1.08
17.56%
from -0.92